Clinical trials recruiting for Castrate Sensitive Prostate Cancer
3
Recruiting trials
11
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Not applicable 2
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Florida | 1 |
| Michigan | 1 |
| Missouri | 1 |
| New York | 1 |
| North Carolina | 1 |
| Oregon | 1 |
| Pennsylvania | 1 |
| Texas | 1 |
| Virginia | 1 |
| Washington | 1 |
Top cities
Ann Arbor, Michigan 1Charlottesville, Virginia 1Houston, Texas 1Los Angeles, California 1New York, New York 1Philadelphia, Pennsylvania 1Portland, Oregon 1Salisbury, North Carolina 1Seattle, Washington 1St Louis, Missouri 1
Self-screener
Recruiting trials
- Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer
- Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)
Related conditions
Trials recruiting for Castrate Sensitive Prostate Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Castrate Sensitive Prostate Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.